1,2-Dioxetane Substrates for Rapid Chemiluminescent Detection

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current chemiluminescent detection reagents, such as acridinium esters and 1,2-dioxetanes, either have long incubation times or lack the combination of flash chemiluminescent signal and ultrasensitive detection with greater substrate stability.

Innovation Solution

Development of compounds with specific structural features that enable rapid light generation, such as 1,2-dioxetanes, which are cleaved by enzyme moieties to produce light within 5-15 minutes at 25°C or 37°C, and can be used in assays for detecting enzymes, antigens, or nucleic acids with enhanced sensitivity and stability.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Loss of time

If direct chemiluminescent labels (acridinium esters or isoluminol) are used, then detection time is reduced, but detection sensitivity and substrate stability are compromised

Engineering Contradiction:
Improvedetection timeVSAvoiddetection sensitivity and substrate stability
Core Design Contradiction:
Loss of timeVSReliability

Solution Approach 1:

The patent modifies the chemical structure of 1,2-dioxetane substrates by introducing specific substituents (aromatic groups, electron-donating groups, solubilizing groups) to change the reaction kinetics parameters. This allows the substrate to exhibit both rapid flash signal generation and enhanced stability, resolving the contradiction between fast detection and reliable sensitivity

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The invention creates composite chemiluminescent substrates that combine the rapid signal characteristics of direct labels with the stability and sensitivity of enzyme-linked substrates. The unique molecular structure integrates features of both approaches, achieving simultaneous fast detection and high reliability

Inventive Principle:
Principle #40Composite materials

2Reliability

If enzyme-linked chemiluminescent substrates (1,2-dioxetanes or luminol) are used, then detection sensitivity and substrate stability are improved, but detection time increases

Engineering Contradiction:
Improvedetection sensitivity and substrate stabilityVSAvoiddetection time
Core Design Contradiction:
ReliabilityVSLoss of time

Solution Approach 1:

The patent optimizes the enzyme-substrate reaction kinetics by modifying the 1,2-dioxetane structure with specific functional groups that increase the rate of enzyme-catalyzed decomposition. This reduces the incubation time required while maintaining the high sensitivity and stability characteristics of enzyme-linked substrates

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

These compounds provide rapid and sensitive detection of analytes, achieving maximum light generation in under 15 minutes, with stability and sensitivity comparable or superior to existing substrates like CDP-Star, suitable for various diagnostic applications.

Implementation Method 1

Chemiluminescent technologies are widely utilized as detection reagents in clinical diagnostic platforms. Direct chemiluminescent labels, such as acridinium esters or isoluminol, provide shorter detection times due to the flash chemiluminescent signal being generated immediately after addition of triggering solutions.

Methodology Applied
Scientific EffectChemiluminescence: Chemiluminescence

Data Source

PatentEP2705031B1Flash and glow 1,2-dioxetanes
Publication Date: 2018.04.11 LIFE TECHNOLOGIES CORP
  • EP2705031B1 patent drawingFigure 1
  • EP2705031B1 patent drawingFigure 2
  • EP2705031B1 patent drawingFigure 3

AI summary

Compounds having chemiluminescent flash and glow properties. Also disclosed are methods using the compounds to generate light, detect and/or quantify enzymes, antigens, and/or nucleic acids. Also disclosed are kits relating to these compounds.